N/A
N=15
A New Approach for Controlling Hemostasis During Canal Treatment: a Pilot Study
Blood Contamination of Root Canal During Endodontic Therapy
Bottom Line
View on ClinicalTrials.gov: NCT03060486 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcome: Primary: Change From Baseline in Root Canal Bleeding Score — 2.33; 0.13 score on a scale — p=<.0001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- HYBENX® (Device)
- Age
- Adult · 20+ yrs
- Sex
- All
- Sponsor
- Dr Riccardo Pace
- Primary completion
- Jan 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Root Canal Bleeding Score |
2.33; 0.13 | <.0001 sig |
Summary
Blood contamination, such as apical microleakage, of root canal during preparation can be a major problem in endodontics. The purpose of this investigation was to evaluate the hemostatic properties of sulfonic/sulfuric acid solution used during root canal therapy in teeth with irreversible pulpitis.
Eligibility Criteria
Inclusion Criteria
- tooth affected by irreversible pulpitis, single-rooted teeth associated with healthy periodontium, physiologic sulcus depth (<3 mm), and absence of bleeding on probing of the involved teeth.
Exclusion Criteria
- patients with systemic diseases using anticoagulants, antibiotics, or anti-inflammatory therapies in the last 30 days, patients with allergy to sulfur in any form, and pregnancy.
Data sourced from ClinicalTrials.gov (NCT03060486). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.